Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gajdos

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 3, 1998
Effective long-term inhibition of thromboxane production but not of serotonin release in patients with coronary heart disease by 30 mg/d acetylsalicylic acid dosageM Gajdos, V Spustová, K Sebeková, et al.
Biopharmaceutics & Drug Disposition|July 1, 1993
The use of a nonlinear absorption model in the study of ascorbic acid bioavailability in manV K Piotrovskij, Z Kállay, M Gajdos, et al.
Bratislavske Lekarske Listy|June 19, 2015
High-frequency - Spinal Cord StimulationR Rapcan, J Mlaka, M Venglarcik, et al.
Bratislavske Lekarske Listy|September 1, 1994
[Prevention of progression in nephropathies]R Dzúrik, V Dzúriková, A Oksa, et al.
Kidney & Blood Pressure Research|April 15, 2000
Enalapril inhibits growth and proliferation of various tissues in rat normotensive four-sixths kidney ablation nephropathyM Gajdos, Z Krivosíková, K Sebeková, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1995
Pharmacokinetics of acetylsalicylic acid and its metabolites at low doses: a compartmental modelingD Dubovská, V K Piotrovskij, M Gajdos, et al.
Physiological Research|December 10, 2002
Serum ex vivo lipoprotein oxidizability in patients with ischemic heart disease supplemented with vitamin EA Nagyová, V Mongiellová, Z Krivosíková, et al.
Casopis Lekaru Ceskych|July 27, 1990
[Pefloxacin in the treatment of recurrent urinary tract infections]A Oksa, V Dzúriková, M Gajdos, et al.
Journal of Cardiovascular Pharmacology|October 17, 2001
Ciprofibrate increases plasma concentration of platelet-derived growth factor AB in patients with advanced atherosclerosis and hyperlipidemia independently of its hypolipidemic effectsM Gajdos, V Mongiellová, D Huttová, et al.
Bratislavske Lekarske Listy|October 1, 1990
[Pharmacokinetic modeling in clinical practice: pefloxacin]V Dzúriková, A Krechnáková, E Svĕtlovská, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 3, 1998
Effective long-term inhibition of thromboxane production but not of serotonin release in patients with coronary heart disease by 30 mg/d acetylsalicylic acid dosageM Gajdos, V Spustová, K Sebeková, et al.
Biopharmaceutics & Drug Disposition|July 1, 1993
The use of a nonlinear absorption model in the study of ascorbic acid bioavailability in manV K Piotrovskij, Z Kállay, M Gajdos, et al.
Bratislavske Lekarske Listy|June 19, 2015
High-frequency - Spinal Cord StimulationR Rapcan, J Mlaka, M Venglarcik, et al.
Bratislavske Lekarske Listy|September 1, 1994
[Prevention of progression in nephropathies]R Dzúrik, V Dzúriková, A Oksa, et al.
Kidney & Blood Pressure Research|April 15, 2000
Enalapril inhibits growth and proliferation of various tissues in rat normotensive four-sixths kidney ablation nephropathyM Gajdos, Z Krivosíková, K Sebeková, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1995
Pharmacokinetics of acetylsalicylic acid and its metabolites at low doses: a compartmental modelingD Dubovská, V K Piotrovskij, M Gajdos, et al.
Physiological Research|December 10, 2002
Serum ex vivo lipoprotein oxidizability in patients with ischemic heart disease supplemented with vitamin EA Nagyová, V Mongiellová, Z Krivosíková, et al.
Casopis Lekaru Ceskych|July 27, 1990
[Pefloxacin in the treatment of recurrent urinary tract infections]A Oksa, V Dzúriková, M Gajdos, et al.
Journal of Cardiovascular Pharmacology|October 17, 2001
Ciprofibrate increases plasma concentration of platelet-derived growth factor AB in patients with advanced atherosclerosis and hyperlipidemia independently of its hypolipidemic effectsM Gajdos, V Mongiellová, D Huttová, et al.
Bratislavske Lekarske Listy|October 1, 1990
[Pharmacokinetic modeling in clinical practice: pefloxacin]V Dzúriková, A Krechnáková, E Svĕtlovská, et al.
Pageof 4